DK0830600T3 - Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister - Google Patents

Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister

Info

Publication number
DK0830600T3
DK0830600T3 DK96918089T DK96918089T DK0830600T3 DK 0830600 T3 DK0830600 T3 DK 0830600T3 DK 96918089 T DK96918089 T DK 96918089T DK 96918089 T DK96918089 T DK 96918089T DK 0830600 T3 DK0830600 T3 DK 0830600T3
Authority
DK
Denmark
Prior art keywords
gpcrs
antagonists
identify
indicator cells
protein
Prior art date
Application number
DK96918089T
Other languages
Danish (da)
English (en)
Inventor
David I Israel
Christopher J Molineaux
Original Assignee
Praecis Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23905512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0830600(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Praecis Pharm Inc filed Critical Praecis Pharm Inc
Application granted granted Critical
Publication of DK0830600T3 publication Critical patent/DK0830600T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK96918089T 1995-06-07 1996-06-05 Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister DK0830600T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47980395A 1995-06-07 1995-06-07
PCT/US1996/008895 WO1996041169A1 (en) 1995-06-07 1996-06-05 Functional bioassay for g-protein coupled receptor agonists and antagonists

Publications (1)

Publication Number Publication Date
DK0830600T3 true DK0830600T3 (da) 2003-12-22

Family

ID=23905512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918089T DK0830600T3 (da) 1995-06-07 1996-06-05 Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister

Country Status (8)

Country Link
EP (1) EP0830600B1 (de)
JP (1) JPH11507518A (de)
AT (1) ATE248373T1 (de)
AU (1) AU730875C (de)
CA (1) CA2220715C (de)
DE (1) DE69629684T2 (de)
DK (1) DK0830600T3 (de)
WO (1) WO1996041169A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2186979A1 (en) * 1996-10-02 1998-04-02 Michael Dennis Methods of testing antagonists for their abilities to affect the activity of g protein-coulpled receptors
CA2192754A1 (en) 1996-12-12 1998-06-12 Jacques Drouin Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor
US6403305B1 (en) * 1997-02-06 2002-06-11 Cornell Research Foundation, Inc. Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor
EP0878542A3 (de) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation CDNS Klon HMTMF81 der für einen neuen menschlichen 7-Transmembranrezeptor kodiert
EP0874047A3 (de) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation CDNS Klon HMTMF81 der für einen neuen menschlichen 7-Transmembranrezeptor kodiert
EP1025256A2 (de) * 1997-10-09 2000-08-09 Ixsys, Incorporated Verfahren zur identifizierung von mit rezeptoren gebundenen ligenden
ATE432472T1 (de) * 1998-07-31 2009-06-15 Arena Pharm Inc Endogene, konstitutiv aktivierte g-protein gekoppelte waisenrezeptoren
EP1242824A2 (de) * 1999-12-30 2002-09-25 7TM Pharma Screeningverfahren unter verwendung von biologischen zielmolekülen mit metallionen-bindungsstellen
WO2002006838A1 (fr) 2000-07-17 2002-01-24 Chugai Seiyaku Kabushiki Kaisha Methode de criblage d'un ligand dote d'une activite biologique
US6902902B2 (en) * 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
EP2490021A1 (de) 2011-02-18 2012-08-22 Biotempt B.V. Modulatoren von PRR- und GPCR-Signalisierung
KR101452864B1 (ko) 2011-11-17 2014-11-04 서울대학교산학협력단 Ｇｐｃｒ19 경로의 활성화에 의한 골수 유래 면역 조절 세포 및 면역 조절 ｂ 림프구의 체내외 증폭

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003137A1 (en) * 1991-08-07 1993-02-18 Washington University Human substance p receptor
WO1994000590A1 (en) * 1992-06-23 1994-01-06 The Mt. Sinai School Of Medicine Of The City University Of New York Cloning and expression of gonadotropin-releasing hormone receptor
EP0666906A4 (de) * 1992-10-15 1997-06-18 Merck & Co Inc Humane endothelinrezeptoren exprimierende cho-zellen.
GB2283239A (en) * 1993-10-29 1995-05-03 Ucb Sa Human H1 histamine receptor
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor

Also Published As

Publication number Publication date
AU6043796A (en) 1996-12-30
CA2220715A1 (en) 1996-12-19
CA2220715C (en) 2004-11-02
WO1996041169A1 (en) 1996-12-19
ATE248373T1 (de) 2003-09-15
DE69629684D1 (de) 2003-10-02
EP0830600A1 (de) 1998-03-25
DE69629684T2 (de) 2004-02-26
EP0830600B1 (de) 2003-08-27
AU730875B2 (en) 2001-03-15
AU730875C (en) 2003-01-16
JPH11507518A (ja) 1999-07-06
EP0830600A4 (de) 2000-04-05

Similar Documents

Publication Publication Date Title
DK0830600T3 (da) Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister
Moore et al. Cell-based versus isolated target screening: how lucky do you feel?
Sugden et al. Melatonin receptor pharmacology: toward subtype specificity
Kassack et al. Functional screening of G protein–coupled receptors by measuring intracellular calcium with a fluorescence microplate reader
Gao et al. Allosteric modulation and functional selectivity of G protein-coupled receptors
Liu et al. Gα16/z chimeras efficiently link a wide range of G protein–coupled receptors to calcium mobilization
Lin et al. Rapid measurements of intracellular calcium using a fluorescence plate reader
Nambi et al. G protein-coupled receptors in drug discovery
WO2000049416A3 (en) Receptor assay for detecting an effect test compounds have on a particular membrane receptor
AU8749498A (en) Methods for identifying or screening agonists for and antagonists to ppar
CA2279881A1 (en) A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
Price et al. FlexStation examination of 5-HT3 receptor function using Ca2+-and membrane potential-sensitive dyes: advantages and potential problems
Onaran et al. Conceptual and experimental issues in biased agonism
EP1266037B1 (de) High throughput screening durch messen der intrazellulären kalziumspiegel
Allen et al. A homogeneous high throughput nonradioactive method for measurement of functional activity of Gs-coupled receptors in membranes
WO2006031322A3 (en) Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis
Reinscheid et al. High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels
Zhang et al. Action of alpha 2A-adrenergic receptors in circular smooth muscle of canine proximal colon
Lundin et al. Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells
WO1999055901A3 (en) Screening assay for identifying human purinoreceptor ligands
Lovenberg et al. D1 dopamine receptors of NS20Y neuroblastoma cells are functionally similar to rat striatal D1 receptors
US7238213B2 (en) Cell-based assays employing voltage and calcium dyes
Goetz et al. A combination assay for simultaneous assessment of multiple signaling pathways
Gorbet et al. A miniature radioimmunoassay for melatonin for use with small samples from invertebrates
Kowal et al. Functional calcium coupling with the human metabotropic glutamate receptor subtypes 2 and 4 by stable co-expression with a calcium pathway facilitating G-protein chimera in Chinese hamster ovary cells